際際滷

際際滷Share a Scribd company logo
LEPTOSPIROSIS
KASIGAIRE DANIEL MUTOME
2021-08-07054
BMS 4.2 KIU
Outline
Defn
Epidemiology
Pathophysiology
Clinical manifestations
Diagnosis
Treatment
Prognosis
 Definition
Leptospirosis is a widespread and potentially fatal
infectious disease affecting both humans and animals
(zoonosis) that is caused by pathogenic spirochetes of
the genus Leptospira
A k.a Weil's disease, Swineherd's disease, rice-field
fever, waterborne fever, nanukayami fever, cane-
cutter fever, swamp fever, mud fever, Fort Bragg
fever, Stuttgart disease, Mgunda fever, and Canicola
fever e.t.c
LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx
Epidemiology
Lepospirosis is considered the most common
zoonosis in the world and is associated with settings of
; poor sanitation and agricultural occupations involving
contact with animals or water. Increasingly,
adventurous travel and"mud run" sports or races
involving fresh water or soil exposure put humans at
risk.
Other epidemiologic factors are linked to specific
hosts. Hosts vary in susceptibility depending on age,
genetic factors (e.g., HLA-DQ6), skin integrity, and
whether protective clothing (e.g., gloves and boots)
are worn.
 The prevalence of leptospirosis in Uganda varies by
study, but is generally estimated to be between 35%
and 4.7%: A study of patients at Mulago National
Referral Hospital found a prevalence of 4.7%.
 Another study found that 35% of participants in
Hoima District were seropositive for Leptospira
antibodies.
 Globally , leptospirosis has caused more than one
million cases and 58,900 deaths per year.
 It's estimated that leptospirosis causes about 2.9
million disability-adjusted life-years (DALYs) lost
worldwide.
Pathophysiology
 When high levels of leptospiremia occur during
infection, innate immune mechanisms eventually
trigger tissue-based and systemic responses to
infection that lead to severe outcomes such as a
sepsis-like syndrome or organ failure.
 Patients with severe leptospirosis have evidence of
a cytokine storm with higher levels of IL-6, TNF-
alpha, and a number of other cytokines than
patients with mild disease
LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx
Clinical manifestations
Leptospirosis ranges in severity from asymptomatic to a mild illness Or to a
multisystemic syndrome with unique features.
Mild illness is unspecific and characterized by sudden onset of the followingthat
are also present in other causes of acute febrile syndrome ie malaria, dengue fever
and influenza :
 Fever (38-40属C)
 Rigors
 Headache, retro-orbital pain, photophobia
 Muscle pain localized to the calf and lumbar areas
 Conjunctival suffusion
 Dry cough
 Nausea and vomiting, diarrhea
More severe disease manifests as icteric leptospirosis, also known as Weil's
disease, with the following features:
 Icterus or frank jaundice
 Renal failure with oliguria
 Hemorrhagic features
 Systemic inflammatory syndrome or shock
LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx
LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx
Investigations and diagnosis
Laboratory studies used to confirm the diagnosis of
leptospirosis include the following:
a. Microscopic agglutination testing (MAT; criterion
standard for serologic identification of leptospires,
available at reference laboratories)
b. Single titer 1:200 or 4-fold rise in serum drawn
between the first and fourth week of illness is
considered diagnostic
c. DNA PCR of blood, urine, CSF, tissue
d. Culture of leptospires from body fluids or tissue
(criterion standard, but requires specific media and
several weeks incubation, thus usually limited to
reference laboratory)
Treatment
 In most cases, leptospirosis is characterized by mild
clinical signs, which can improve spontaneously
 oral doxycycline is recommended for the
treatment of mild leptospirosis.
 In this regard, it is recommended to consume a dose
of 100 mg doxycycline twice a day for a week.
 Amoxicillin (500 mg/day for 1 week to 10 days)
 ampicillin (500750 mg/day for 1 week to 10 days)
 azithromycin (500 mg/day for 3 days) can also be
orally administered .
Cont.
Patients with severe leptospirosis, which normally
manifests as renal and hepatic failure, are
administered penicillin G (penicillin G sodium; at a
dose of 1.5 million U/6 IV for a week .
Amoxicillin and azithromycin should be
administered to children and pregnant women
instead of doxycycline .
Prevention
This involves ;
Rodent control
Avoid contact with water contaminated by animals
Vaccination for both humans and animals
Prognosis of leptospirosis
 The mild form of leptospirosis rarely is fatal, and
an estimated 90% of cases fall into this category.
 The mortality rate in severe leptospirosis averages
approximately 10%, but has been described as
ranging from 5-40%.
 Elderly and immunocompromised people are at
the highest risk for mortality overall. Most deaths
occur from renal failure, massive hemorrhage, or
acute respiratory distress syndrome (ARDS).
References
1. Palaniappan RU, Ramanujam S, Chang YF.
Leptospirosis: pathogenesis, immunity, and
diagnosis. Curr Opin Infect Dis. 2007 Jun.
20(3):284-92. [QxMD MEDLINE Link].
2. CDC. From the Centers for Disease Control and
Prevention. Update: outbreak of acute febrile illness
among athletes participating in Eco-Challenge-Sabah
2000--Borneo, Malaysia, 2000. JAMA. 2001 Feb 14.
285(6):728-30.
3. Abela-Ridder B, Sikkema R, Hartskeerl RA.
Estimating the burden of human leptospirosis. Int J
Antimicrob Agents. 2010;36(Suppl 1):S5S7. doi:
4. Beri, D., Moola, S., Jagnoor, J., Salam, A., and
Bhaumik, S. (2021). Prevention, control and
management of leptospirosis in India: an evidence gap
map. Trans. R. Soc. Trop. Med. Hyg. 115, 13531361.
doi: 10.1093/trstmh/trab036.
5. Chacko, C. S., Jayakumar, A., Binu, S. L., Pant, R. D.,
Giri, A., Chand, S., et al. (2021). A short review on
leptospirosis: clinical manifestations, diagnosis and
treatment. Clin Epidemiol Global Health. 11:100741.
doi: 10.1016/j.cegh.2021.100741

More Related Content

Similar to LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx (20)

Leptospirosis
Leptospirosis Leptospirosis
Leptospirosis
Ade Wijaya
Crimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic FeverCrimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic Fever
Bhagawana Ram
Typhoid neo
Typhoid neoTyphoid neo
Typhoid neo
Nawin Kumar
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
WAidid
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Zaim Zawawi
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Zaim Zawawi
Leptospirosis .pptx
Leptospirosis                      .pptxLeptospirosis                      .pptx
Leptospirosis .pptx
ssuserded5ff
TYPHOID FEVER edited.pptx00000000000000
TYPHOID FEVER  edited.pptx00000000000000TYPHOID FEVER  edited.pptx00000000000000
TYPHOID FEVER edited.pptx00000000000000
samuellamaryk
DENGUE Fever and other symptoms of dengue fever
DENGUE Fever and other symptoms of dengue feverDENGUE Fever and other symptoms of dengue fever
DENGUE Fever and other symptoms of dengue fever
jaweria0036
Approach to acute febrile illness in Tropical regions
Approach to acute febrile illness in Tropical regions Approach to acute febrile illness in Tropical regions
Approach to acute febrile illness in Tropical regions
YMC Medicine
Dengue fver
Dengue fverDengue fver
Dengue fver
Dinesh Pawar
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Manjit Tendolkar
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Amandeep Kaur
Dengue fever
Dengue fever Dengue fever
Dengue fever
Pubali Biswas
Dengue fever
Dengue feverDengue fever
Dengue fever
Nirav Dhinoja
Acute Rheumatic Fever ppppppppooopop.pdf
Acute Rheumatic Fever ppppppppooopop.pdfAcute Rheumatic Fever ppppppppooopop.pdf
Acute Rheumatic Fever ppppppppooopop.pdf
Upendo23
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and PreventionLeptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Crisbert Cualteros
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptxOverview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
ssuser6de8b3
Lecture 15. hemorrhagic fevers
Lecture 15. hemorrhagic feversLecture 15. hemorrhagic fevers
Lecture 15. hemorrhagic fevers
Vasyl Sorokhan
Typhoid Fever
Typhoid FeverTyphoid Fever
Typhoid Fever
drnooruddin
Leptospirosis
Leptospirosis Leptospirosis
Leptospirosis
Ade Wijaya
Crimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic FeverCrimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic Fever
Bhagawana Ram
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
Infections and salivary gland disease in pediatric age: how to manage - 際際滷...
WAidid
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Zaim Zawawi
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
Zaim Zawawi
Leptospirosis .pptx
Leptospirosis                      .pptxLeptospirosis                      .pptx
Leptospirosis .pptx
ssuserded5ff
TYPHOID FEVER edited.pptx00000000000000
TYPHOID FEVER  edited.pptx00000000000000TYPHOID FEVER  edited.pptx00000000000000
TYPHOID FEVER edited.pptx00000000000000
samuellamaryk
DENGUE Fever and other symptoms of dengue fever
DENGUE Fever and other symptoms of dengue feverDENGUE Fever and other symptoms of dengue fever
DENGUE Fever and other symptoms of dengue fever
jaweria0036
Approach to acute febrile illness in Tropical regions
Approach to acute febrile illness in Tropical regions Approach to acute febrile illness in Tropical regions
Approach to acute febrile illness in Tropical regions
YMC Medicine
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)Monsoon Illnesses affecting Lungs (Part 1 of 2)
Monsoon Illnesses affecting Lungs (Part 1 of 2)
Manjit Tendolkar
Acute Rheumatic Fever ppppppppooopop.pdf
Acute Rheumatic Fever ppppppppooopop.pdfAcute Rheumatic Fever ppppppppooopop.pdf
Acute Rheumatic Fever ppppppppooopop.pdf
Upendo23
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and PreventionLeptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Leptospirosis Clinical Manifestations, Diagnosis, Treatment and Prevention
Crisbert Cualteros
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptxOverview of viral haemorrhagic fevers with focus on Lassa fever.pptx
Overview of viral haemorrhagic fevers with focus on Lassa fever.pptx
ssuser6de8b3
Lecture 15. hemorrhagic fevers
Lecture 15. hemorrhagic feversLecture 15. hemorrhagic fevers
Lecture 15. hemorrhagic fevers
Vasyl Sorokhan
Typhoid Fever
Typhoid FeverTyphoid Fever
Typhoid Fever
drnooruddin

More from Ahemigisha (20)

School health Programes.Group five.pptxaksjndjd
School health Programes.Group five.pptxaksjndjdSchool health Programes.Group five.pptxaksjndjd
School health Programes.Group five.pptxaksjndjd
Ahemigisha
Group 8 HMS-1.pptx1918839839393848985994
Group 8 HMS-1.pptx1918839839393848985994Group 8 HMS-1.pptx1918839839393848985994
Group 8 HMS-1.pptx1918839839393848985994
Ahemigisha
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhfGROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
Ahemigisha
Grp7 2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Grp7  2025, EPIDEMIC MANAGEMENT.pptxvahjhshsjGrp7  2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Grp7 2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Ahemigisha
Acquired diseases-of-the-esophagus.pptxdgghjh
Acquired diseases-of-the-esophagus.pptxdgghjhAcquired diseases-of-the-esophagus.pptxdgghjh
Acquired diseases-of-the-esophagus.pptxdgghjh
Ahemigisha
Types-of-Hernia-and-Its-Management.pptxfhhgjj
Types-of-Hernia-and-Its-Management.pptxfhhgjjTypes-of-Hernia-and-Its-Management.pptxfhhgjj
Types-of-Hernia-and-Its-Management.pptxfhhgjj
Ahemigisha
abnormalities of amniotic fluid by Vicenty.pptx
abnormalities of amniotic fluid by Vicenty.pptxabnormalities of amniotic fluid by Vicenty.pptx
abnormalities of amniotic fluid by Vicenty.pptx
Ahemigisha
Colorectal Cancer in surgery.pptxakdkdjnd
Colorectal  Cancer in surgery.pptxakdkdjndColorectal  Cancer in surgery.pptxakdkdjnd
Colorectal Cancer in surgery.pptxakdkdjnd
Ahemigisha
PROSTATE CANCER by DANIEL MUTOME.pptx16819
PROSTATE CANCER by DANIEL MUTOME.pptx16819PROSTATE CANCER by DANIEL MUTOME.pptx16819
PROSTATE CANCER by DANIEL MUTOME.pptx16819
Ahemigisha
CANCER OF THE PENIS BMS 4.2 updated-2.pptx
CANCER OF THE PENIS BMS 4.2 updated-2.pptxCANCER OF THE PENIS BMS 4.2 updated-2.pptx
CANCER OF THE PENIS BMS 4.2 updated-2.pptx
Ahemigisha
haemostasis and blood transfusion in surgery KIU.pptx
haemostasis and blood transfusion in surgery KIU.pptxhaemostasis and blood transfusion in surgery KIU.pptx
haemostasis and blood transfusion in surgery KIU.pptx
Ahemigisha
abdominal wall hernias136789688588588.pptx
abdominal wall hernias136789688588588.pptxabdominal wall hernias136789688588588.pptx
abdominal wall hernias136789688588588.pptx
Ahemigisha
APPENDICITIS DR BIENFAIT246578+89788.pptx
APPENDICITIS DR BIENFAIT246578+89788.pptxAPPENDICITIS DR BIENFAIT246578+89788.pptx
APPENDICITIS DR BIENFAIT246578+89788.pptx
Ahemigisha
Inflamatory bowel disease.1332446677pptx
Inflamatory bowel disease.1332446677pptxInflamatory bowel disease.1332446677pptx
Inflamatory bowel disease.1332446677pptx
Ahemigisha
GI bleeding Gastrointestinal presentation.pptx
GI bleeding Gastrointestinal presentation.pptxGI bleeding Gastrointestinal presentation.pptx
GI bleeding Gastrointestinal presentation.pptx
Ahemigisha
UGIB VS LGIB.interstinal bleeding 123939pptx
UGIB VS LGIB.interstinal bleeding 123939pptxUGIB VS LGIB.interstinal bleeding 123939pptx
UGIB VS LGIB.interstinal bleeding 123939pptx
Ahemigisha
Glomerular diseases.1236384747848488pptx
Glomerular  diseases.1236384747848488pptxGlomerular  diseases.1236384747848488pptx
Glomerular diseases.1236384747848488pptx
Ahemigisha
PNEUMONIA12345949489494938393893893839pptx
PNEUMONIA12345949489494938393893893839pptxPNEUMONIA12345949489494938393893893839pptx
PNEUMONIA12345949489494938393893893839pptx
Ahemigisha
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptxDISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
Ahemigisha
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptxCARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
Ahemigisha
School health Programes.Group five.pptxaksjndjd
School health Programes.Group five.pptxaksjndjdSchool health Programes.Group five.pptxaksjndjd
School health Programes.Group five.pptxaksjndjd
Ahemigisha
Group 8 HMS-1.pptx1918839839393848985994
Group 8 HMS-1.pptx1918839839393848985994Group 8 HMS-1.pptx1918839839393848985994
Group 8 HMS-1.pptx1918839839393848985994
Ahemigisha
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhfGROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
GROUP 3.pptxsgajskhdmodhdfjhfgrohrjfhjddjhf
Ahemigisha
Grp7 2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Grp7  2025, EPIDEMIC MANAGEMENT.pptxvahjhshsjGrp7  2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Grp7 2025, EPIDEMIC MANAGEMENT.pptxvahjhshsj
Ahemigisha
Acquired diseases-of-the-esophagus.pptxdgghjh
Acquired diseases-of-the-esophagus.pptxdgghjhAcquired diseases-of-the-esophagus.pptxdgghjh
Acquired diseases-of-the-esophagus.pptxdgghjh
Ahemigisha
Types-of-Hernia-and-Its-Management.pptxfhhgjj
Types-of-Hernia-and-Its-Management.pptxfhhgjjTypes-of-Hernia-and-Its-Management.pptxfhhgjj
Types-of-Hernia-and-Its-Management.pptxfhhgjj
Ahemigisha
abnormalities of amniotic fluid by Vicenty.pptx
abnormalities of amniotic fluid by Vicenty.pptxabnormalities of amniotic fluid by Vicenty.pptx
abnormalities of amniotic fluid by Vicenty.pptx
Ahemigisha
Colorectal Cancer in surgery.pptxakdkdjnd
Colorectal  Cancer in surgery.pptxakdkdjndColorectal  Cancer in surgery.pptxakdkdjnd
Colorectal Cancer in surgery.pptxakdkdjnd
Ahemigisha
PROSTATE CANCER by DANIEL MUTOME.pptx16819
PROSTATE CANCER by DANIEL MUTOME.pptx16819PROSTATE CANCER by DANIEL MUTOME.pptx16819
PROSTATE CANCER by DANIEL MUTOME.pptx16819
Ahemigisha
CANCER OF THE PENIS BMS 4.2 updated-2.pptx
CANCER OF THE PENIS BMS 4.2 updated-2.pptxCANCER OF THE PENIS BMS 4.2 updated-2.pptx
CANCER OF THE PENIS BMS 4.2 updated-2.pptx
Ahemigisha
haemostasis and blood transfusion in surgery KIU.pptx
haemostasis and blood transfusion in surgery KIU.pptxhaemostasis and blood transfusion in surgery KIU.pptx
haemostasis and blood transfusion in surgery KIU.pptx
Ahemigisha
abdominal wall hernias136789688588588.pptx
abdominal wall hernias136789688588588.pptxabdominal wall hernias136789688588588.pptx
abdominal wall hernias136789688588588.pptx
Ahemigisha
APPENDICITIS DR BIENFAIT246578+89788.pptx
APPENDICITIS DR BIENFAIT246578+89788.pptxAPPENDICITIS DR BIENFAIT246578+89788.pptx
APPENDICITIS DR BIENFAIT246578+89788.pptx
Ahemigisha
Inflamatory bowel disease.1332446677pptx
Inflamatory bowel disease.1332446677pptxInflamatory bowel disease.1332446677pptx
Inflamatory bowel disease.1332446677pptx
Ahemigisha
GI bleeding Gastrointestinal presentation.pptx
GI bleeding Gastrointestinal presentation.pptxGI bleeding Gastrointestinal presentation.pptx
GI bleeding Gastrointestinal presentation.pptx
Ahemigisha
UGIB VS LGIB.interstinal bleeding 123939pptx
UGIB VS LGIB.interstinal bleeding 123939pptxUGIB VS LGIB.interstinal bleeding 123939pptx
UGIB VS LGIB.interstinal bleeding 123939pptx
Ahemigisha
Glomerular diseases.1236384747848488pptx
Glomerular  diseases.1236384747848488pptxGlomerular  diseases.1236384747848488pptx
Glomerular diseases.1236384747848488pptx
Ahemigisha
PNEUMONIA12345949489494938393893893839pptx
PNEUMONIA12345949489494938393893893839pptxPNEUMONIA12345949489494938393893893839pptx
PNEUMONIA12345949489494938393893893839pptx
Ahemigisha
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptxDISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
DISORDERS OF CARDIAC RHYTHM- MORRIS.pptx
Ahemigisha
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptxCARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
CARDIOMYOPATHIES DR NIXSONa at thhggh.pptx
Ahemigisha

Recently uploaded (20)

Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
Endocarditis.pptx
Endocarditis.pptxEndocarditis.pptx
Endocarditis.pptx
Nandish Sannaiah
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERDIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
daminipatel37
psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
4. Cardiac cycle.pptx cardiovascular system
4. Cardiac cycle.pptx cardiovascular system4. Cardiac cycle.pptx cardiovascular system
4. Cardiac cycle.pptx cardiovascular system
Pooja Rani
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERDIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
daminipatel37
psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
4. Cardiac cycle.pptx cardiovascular system
4. Cardiac cycle.pptx cardiovascular system4. Cardiac cycle.pptx cardiovascular system
4. Cardiac cycle.pptx cardiovascular system
Pooja Rani
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37

LEPTOSPIROSIS-DANIEL MUTOME12345678.pptx

  • 3. Definition Leptospirosis is a widespread and potentially fatal infectious disease affecting both humans and animals (zoonosis) that is caused by pathogenic spirochetes of the genus Leptospira A k.a Weil's disease, Swineherd's disease, rice-field fever, waterborne fever, nanukayami fever, cane- cutter fever, swamp fever, mud fever, Fort Bragg fever, Stuttgart disease, Mgunda fever, and Canicola fever e.t.c
  • 5. Epidemiology Lepospirosis is considered the most common zoonosis in the world and is associated with settings of ; poor sanitation and agricultural occupations involving contact with animals or water. Increasingly, adventurous travel and"mud run" sports or races involving fresh water or soil exposure put humans at risk. Other epidemiologic factors are linked to specific hosts. Hosts vary in susceptibility depending on age, genetic factors (e.g., HLA-DQ6), skin integrity, and whether protective clothing (e.g., gloves and boots) are worn.
  • 6. The prevalence of leptospirosis in Uganda varies by study, but is generally estimated to be between 35% and 4.7%: A study of patients at Mulago National Referral Hospital found a prevalence of 4.7%. Another study found that 35% of participants in Hoima District were seropositive for Leptospira antibodies. Globally , leptospirosis has caused more than one million cases and 58,900 deaths per year. It's estimated that leptospirosis causes about 2.9 million disability-adjusted life-years (DALYs) lost worldwide.
  • 8. When high levels of leptospiremia occur during infection, innate immune mechanisms eventually trigger tissue-based and systemic responses to infection that lead to severe outcomes such as a sepsis-like syndrome or organ failure. Patients with severe leptospirosis have evidence of a cytokine storm with higher levels of IL-6, TNF- alpha, and a number of other cytokines than patients with mild disease
  • 10. Clinical manifestations Leptospirosis ranges in severity from asymptomatic to a mild illness Or to a multisystemic syndrome with unique features. Mild illness is unspecific and characterized by sudden onset of the followingthat are also present in other causes of acute febrile syndrome ie malaria, dengue fever and influenza : Fever (38-40属C) Rigors Headache, retro-orbital pain, photophobia Muscle pain localized to the calf and lumbar areas Conjunctival suffusion Dry cough Nausea and vomiting, diarrhea More severe disease manifests as icteric leptospirosis, also known as Weil's disease, with the following features: Icterus or frank jaundice Renal failure with oliguria Hemorrhagic features Systemic inflammatory syndrome or shock
  • 14. Laboratory studies used to confirm the diagnosis of leptospirosis include the following: a. Microscopic agglutination testing (MAT; criterion standard for serologic identification of leptospires, available at reference laboratories) b. Single titer 1:200 or 4-fold rise in serum drawn between the first and fourth week of illness is considered diagnostic c. DNA PCR of blood, urine, CSF, tissue d. Culture of leptospires from body fluids or tissue (criterion standard, but requires specific media and several weeks incubation, thus usually limited to reference laboratory)
  • 15. Treatment In most cases, leptospirosis is characterized by mild clinical signs, which can improve spontaneously oral doxycycline is recommended for the treatment of mild leptospirosis. In this regard, it is recommended to consume a dose of 100 mg doxycycline twice a day for a week. Amoxicillin (500 mg/day for 1 week to 10 days) ampicillin (500750 mg/day for 1 week to 10 days) azithromycin (500 mg/day for 3 days) can also be orally administered .
  • 16. Cont. Patients with severe leptospirosis, which normally manifests as renal and hepatic failure, are administered penicillin G (penicillin G sodium; at a dose of 1.5 million U/6 IV for a week . Amoxicillin and azithromycin should be administered to children and pregnant women instead of doxycycline .
  • 17. Prevention This involves ; Rodent control Avoid contact with water contaminated by animals Vaccination for both humans and animals
  • 18. Prognosis of leptospirosis The mild form of leptospirosis rarely is fatal, and an estimated 90% of cases fall into this category. The mortality rate in severe leptospirosis averages approximately 10%, but has been described as ranging from 5-40%. Elderly and immunocompromised people are at the highest risk for mortality overall. Most deaths occur from renal failure, massive hemorrhage, or acute respiratory distress syndrome (ARDS).
  • 19. References 1. Palaniappan RU, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007 Jun. 20(3):284-92. [QxMD MEDLINE Link]. 2. CDC. From the Centers for Disease Control and Prevention. Update: outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000--Borneo, Malaysia, 2000. JAMA. 2001 Feb 14. 285(6):728-30. 3. Abela-Ridder B, Sikkema R, Hartskeerl RA. Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010;36(Suppl 1):S5S7. doi:
  • 20. 4. Beri, D., Moola, S., Jagnoor, J., Salam, A., and Bhaumik, S. (2021). Prevention, control and management of leptospirosis in India: an evidence gap map. Trans. R. Soc. Trop. Med. Hyg. 115, 13531361. doi: 10.1093/trstmh/trab036. 5. Chacko, C. S., Jayakumar, A., Binu, S. L., Pant, R. D., Giri, A., Chand, S., et al. (2021). A short review on leptospirosis: clinical manifestations, diagnosis and treatment. Clin Epidemiol Global Health. 11:100741. doi: 10.1016/j.cegh.2021.100741

Editor's Notes

  • #3: Leptospira are gram negative spirochetes( have a flexible and helix shape).
  • #6: In Uganda , the latest outbreak of leptospirosis was noted in Kabale district, 2017.